About Wesper

More patients tested for sleep apnea.

Wesper was founded in New York in 2017 to close the gap between the patients who need a sleep study and the ones who get one. Today we develop FDA-cleared home sleep tests and run a multi-tier sleep testing ecosystem for providers across the U.S.

A patient receiving a Wesper test kit at home
Wesper Lab sensor patches

Our Mission

Personalized sleep testing. Personalized care.

Wesper gives healthcare providers reliable, high-resolution sleep data, and runs the logistics around it, so clinical teams can focus on care, access and growth.

We are committed to advancing sleep science through innovation, simplicity and trust, because better sleep changes lives.

Wesper at a Glance

Founded in 2017, in New York.

Backed by Valor Equity Partners, Breyer Capital and Spark Capital.

2017

Founded in New York

50

States with access to board-certified sleep physicians

45+

Longitudinal sleep trends tracked per patient

Our Leadership

The people building Wesper.

Engineers, scientists and operators with backgrounds in flexible electronics, medical imaging, medical devices and sleep research.

Dr. Amir Reuveny

Dr. Amir Reuveny

Co-Founder & CEO

Read bio

Before founding Wesper, Dr. Reuveny was a postdoctoral fellow at Cornell Tech University, investigating commercial applications for flexible electronics. Amir received his Ph.D. in Electrical Engineering and Information Systems from the University of Tokyo and holds a double major degree with honors from Technion, Israel. When he’s not researching sleep habits, you can find him traveling, cooking, relaxing on the beach, and spending time with his family.

Adi Mordechai

Adi Mordechai

CTO

Read bio

Before founding Wesper, Adi was a senior software engineer at Algotec. He pioneered smart analysis of 3D medical images for diagnostic purposes and was the Director of Fraud Prevention at Matrix IF5. Adi holds a B.Sc with honors in Computer Science, Mathematics, and Physics from the Hebrew University, Israel (Talpiyot), and served as a senior software developer in unit 8200 in the Israeli Army. After living in New York City for 12 years, Adi is back with his family in Israel. In his free time, you can find him DIY-ing just about anything and putting together complex puzzles.

Anthony Soha

Anthony Soha

VP of Sales

Read bio

Anthony held senior commercial roles at Abbott and Alere and helped launch diagnostic products at startups including LumiraDx and Universal Biosensors, spanning point-of-care, IDTF and DME markets.

Erik Keener

Erik Keener

VP of Finance

Read bio

Erik has led high-performing finance and accounting functions for scaling startups. He holds a finance degree with high honors from the University of Notre Dame, and is a CFA charterholder and ABFO member.

Devon Lodge

Devon Lodge

Head of Growth

Read bio

Devon has held senior leadership roles across diverse industries bringing a holistic marketing and sales approach grounded in strong operational execution to drive accelerated growth. Educated at Juilliard and Columbia University, he combines analytical rigor with creative strategy through experience leading teams, managing complex campaigns, and scaling both startups and enterprise organizations. When not driving growth at Wesper, Devon enjoys being in nature with his dogs, sailing, and connecting with his community.

Dr. Chelsie Rohrscheib, PhD

Dr. Chelsie Rohrscheib, PhD

Neuroscientist & Sleep Head Researcher

Read bio

Dr. Rohrscheib is a sleep expert, neuroscientist, and sleep consultant with over 10 years of experience in the field of sleep. She holds a bachelor’s degree in Biomedical Science with Honors and a Ph.D. in Neuroscience with a specialty in sleep genetics. She also worked in clinical trials where she oversaw sleep apnea research. Besides living and breathing all things sleep, you can usually find Chelsie cuddling up to her cats (who are probably sleeping) and enjoying a good book!

Evidence

What the data shows.

Wesper has been studied against in-lab polysomnography and against clinicians' own scoring. The source for each result is listed with it.

95%+

AHI correlation to in-lab PSG

Sleep Medicine 2025; JCSM 2023

r = 0.98

Automatic scoring vs. provider manual scoring

Sleep Medicine 2026

<5 days

From order to successful test

Wesper, Q3 2026

99%+

Patient success rate

Wesper, Q3 2026

TIME Best Inventions of 2026, Special Mention. Read the announcement

Get Started

See Wesper in your workflow.

A walkthrough of the devices, the portal and how a Wesper program would run for your patients.